RUFY1 was also shown to interact with podocalyxin-like protein (PODXL), a transmembrane glycoprotein with anti-adhesive properties associated with poor prognosis of several cancers (Taniuchi et al., 2018; He et al., 2020; Table 1). This evidence concerns the gene RUFY1 and cancer.